Analyst Price Targets — MDXG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 23, 2026 6:49 am | — | UBS | $10.00 | $5.17 | StreetInsider | Citizens Starts MiMedx Group (MDXG) at Market Outperform |
| November 15, 2024 11:48 am | Anthony Petrone | Mizuho Securities | $16.00 | $9.09 | StreetInsider | MiMedx Group (MDXG) PT Raised to $16 at Mizuho |
| July 2, 2024 6:15 am | Ross Osborn | Cantor Fitzgerald | $11.00 | $6.70 | TheFly | MiMedx initiated with an Overweight at Cantor Fitzgerald |
| April 29, 2024 8:43 am | Brooks O'Neil | Lake Street | $12.00 | $6.27 | TheFly | Proposed new LCDs likely benefit MiMedx if implemented, says Lake Street |
| September 7, 2022 6:20 am | — | H.C. Wainwright | $8.00 | $3.42 | Benzinga | HC Wainwright & Co. Maintains Buy on MiMedx Group, Lowers Price Target to $8 |
Latest News for MDXG
MiMedx Group, Inc (NASDAQ: MDXG - Get Free Report) hit a new 52-week low during mid-day trading on Friday. The company traded as low as $4.80 and last traded at $4.94, with a volume of 2595097 shares traded. The stock had previously closed at $5.28. Trending Headlines about MiMedx Group Here are the key news
MiMedx (MDXG) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago.
MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript
Net Sales Grew 27% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $15 million and $0.10, Respectively Fourth Quarter Adjusted EBITDA 1 was $29 Million, or 25% of Net Sales Company Estimates 2026 Net Sales in a Range of $340-360 Million Announces $100 Million Share Repurchase Program Authorization Management to Host Conference Call Today,…
MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, February 25, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m.…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MDXG.
U.S. House Trading
No House trades found for MDXG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.